Human anti-CCR4 minibody gene transfer for the treatment of cutaneous T-cell lymphoma.
about
Engineering humoral immunity as prophylaxis or therapyChemokine receptor-specific antibodies in cancer immunotherapy: achievements and challengesAdeno-associated virus-mediated cancer gene therapy: current statusNovel delivery approaches for cancer therapeutics.The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL).Anti-CCR4 monoclonal antibody enhances antitumor immunity by modulating tumor-infiltrating Tregs in an ovarian cancer xenograft humanized mouse modelHumanized mouse G6 anti-idiotypic monoclonal antibody has therapeutic potential against IGHV1-69 germline gene-based B-CLL.Novel therapies for cutaneous T-cell lymphoma: what does the future hold?In situ production of therapeutic monoclonal antibodies.State of play and clinical prospects of antibody gene transfer.Minimalist Antibodies and Mimetics: An Update and Recent Applications.TruSeq-Based Gene Expression Analysis of Formalin-Fixed Paraffin-Embedded (FFPE) Cutaneous T-Cell Lymphoma Samples: Subgroup Analysis Results and Elucidation of Biases from FFPE Sample Processing on the TruSeq Platform.Role of dysregulated cytokine signaling and bacterial triggers in the pathogenesis of Cutaneous T Cell Lymphoma.Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets.CCR4+T cell recruitment to the skin in mycosis fungoides: potential contributions by thymic stromal lymphopoietin and interleukin-16.In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments
P2860
Q26800101-9E6145EF-9804-4ABA-A648-74C9ACC154B3Q26866236-285EF381-40EA-40D1-B6D9-C512BA031068Q27026177-CB5F9EFB-7374-4D32-AE51-9F54C930DBBFQ30368171-4862513B-5D2B-4102-95F4-FDF63EDBDFDEQ35752062-5F8BB2B1-6BD7-4F9C-8752-5BE9FF8952E8Q36821149-53FA089C-0264-4B79-936A-18232E1C7328Q37138991-A9263E8D-BE1B-4907-9535-331F13041C84Q38176398-42EB8A97-6463-4B33-B1C6-750549664709Q38314210-6E6743AA-8260-47BB-A06C-8384D1318FFFQ38737706-36C49A00-EF2C-498A-9D8E-B22EBCDB89CDQ38914281-7559FD4A-1866-4036-BC7C-CE7465271282Q42270898-30F8E5F0-4ADB-4D84-B13E-2DEA17665B7BQ47613529-4622D9E8-8526-4FD1-8B83-DDE050D6CB7EQ49539698-3F0CC7F6-8C62-4ABA-9DDB-1225877D4CD6Q50850403-3EAD151D-D346-417A-8B19-4B9949059137Q56568322-9A1DEE46-7732-49AD-A820-6FE5206C430C
P2860
Human anti-CCR4 minibody gene transfer for the treatment of cutaneous T-cell lymphoma.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Human anti-CCR4 minibody gene transfer for the treatment of cutaneous T-cell lymphoma.
@ast
Human anti-CCR4 minibody gene transfer for the treatment of cutaneous T-cell lymphoma.
@en
Human anti-CCR4 minibody gene transfer for the treatment of cutaneous T-cell lymphoma.
@nl
type
label
Human anti-CCR4 minibody gene transfer for the treatment of cutaneous T-cell lymphoma.
@ast
Human anti-CCR4 minibody gene transfer for the treatment of cutaneous T-cell lymphoma.
@en
Human anti-CCR4 minibody gene transfer for the treatment of cutaneous T-cell lymphoma.
@nl
prefLabel
Human anti-CCR4 minibody gene transfer for the treatment of cutaneous T-cell lymphoma.
@ast
Human anti-CCR4 minibody gene transfer for the treatment of cutaneous T-cell lymphoma.
@en
Human anti-CCR4 minibody gene transfer for the treatment of cutaneous T-cell lymphoma.
@nl
P2093
P2860
P1433
P1476
Human anti-CCR4 minibody gene transfer for the treatment of cutaneous T-cell lymphoma
@en
P2093
Asli Muvaffak
De-Kuan Chang
James Campbell
Thomas Han
Thomas S Kupper
Ussama M Abdel-Motal
Wayne A Marasco
P2860
P304
P356
10.1371/JOURNAL.PONE.0044455
P407
P50
P577
2012-09-04T00:00:00Z